ran GHK-Cu subq for eight weeks last year, 2mg/day, and the viscosity thing is real. here’s what’s going on: GHK-Cu in solution is heavier than most peptides - it’s a copper complex, not a straight-chain amino acid sequence. the surface tension at the needle tip is high enough that when you pull the plunger back after injection, capillary action will drag a small bead back up and then out. it’s not contamination, it’s physics. the slow-pull problem is a gauge issue. most people run BPC or TB at 27-29g and assume GHK works the same. it doesn’t. i ended up dropping to 25g for loading and switching to 27g for injection after warming the vial in my palm for 60-90 seconds. the viscosity drops noticeably with a small temperature change. that alone fixed most of the air-in-syringe issue. the dripping-out-after-withdrawal is separate. after pulling the needle, press a dry gauze pad on the site immediately and hold 5-10 seconds with light pressure. don’t rub. the compound is at the tip of the needle track and rubbing disperses it subq but also wastes some. also worth checking: if your reconstitution volume is low (say, 1ml into a 10mg vial), you’ve got a very concentrated solution that behaves nothing like diluted BPC. i reconstitute GHK at 2ml minimum, sometimes 3ml, to bring the viscosity down to something manageable. air in the syringe after loading is fixable: load slow, tap and purge standing upright, then give it 30 seconds before capping.
something the viscosity discussion sidesteps that’s worth naming: GHK-Cu is photosensitive in a way most peptides aren’t. the copper complex absorbs in the visible range (that’s why the solution is blue) and ambient light exposure over the course of a 30 day open-vial window will degrade the chromophore measurably. amber vial or wrapping the vial in foil between pins is not paranoia, it’s the actual storage spec on most COAs i’ve seen for copper peptides. the other one is diluent choice. bac water is fine for most peptides but benzyl alcohol has a known affinity for transition metal binding, and there’s a low-key debate in compounding about whether it competes with the histidine residues for the copper coordination over time. i’ve seen some 503As reconstitute copper peptides in sterile water and recommend a tighter BUD instead of using BAC. not saying bac ruins it on day one, but if your blue is fading by week 3 that’s a candidate variable separate from temperature or air exposure. ymmv on whether you can see the color shift by eye, but a phone camera under consistent lighting catches it earlier than you’d think.
the “it’s not contamination, it’s physics” line is the part of this that needs to be on every GHK-Cu thread, because the dripback panic almost always reads as a sterility concern when the actual variable is surface tension at the tip. one thing i’d add on the warming step: 60-90 seconds in the palm is taking the solution from roughly fridge temp (2-8c) to skin temp (around 32-34c), and the dynamic viscosity drop across that range is meaningful, not marginal. it’s the same reason hospira BAC pulls easier after a palm warm even though nobody talks about it that way. the reconstitution volume call is the bigger one though. 1ml into a 10mg vial gives you 10mg/ml of a copper-complexed peptide, and that solution behaves more like a thin syrup than a saline draw, especially through a 29g. going to 2-3ml drops you to 3.3-5mg/ml and the draw mechanics change completely, dead space residual included. one thing i’d flag on top: light exposure during the warm-and-load window. amber vial or wrap it, because the cu(ii) complex is photoreactive in ways most peptides aren’t, and a sunny windowsill while you’re prepping isn’t a non-issue. ymmv on how much that actually shifts potency, but the mechanism is there.
the “fading blue” point is worth expanding past aesthetics: if the copper complex is actually dissociating, what’s left isn’t inert. free copper at the injection site is a reactive metal ion, not nothing. whether the amounts involved are clinically relevant at typical 2mg doses is genuinely unclear to me, but it’s a different category of problem than “compound slightly less effective.” the bac water / benzyl alcohol debate people keep having is mostly framed as potency loss, and that framing undersells it. would be curious whether anyone running ghk long-term has checked their copper serum levels periodically, bc i haven’t seen that data surface in any of these threads and it seems like the obvious follow-on question
the steel-man here is solid: free copper ion isn’t inert, and “less potent” framing does undersell a dissociation event because you’ve changed what’s actually sitting at the injection site, not just how much active compound is there. agreed that’s a different category of problem than benzyl alcohol potency loss. where i’d push back is on serum copper as the obvious follow-on. it’s intuitive but probably the wrong assay for what you’re worried about. serum copper is held pretty tight by ceruloplasmin (something like 85-95% of circulating copper is bound), and the homeostatic range is narrow enough that a 2mg/day ghk dose, which carries maybe 0.3-0.4mg of copper in the complex, is well under typical dietary intake (~1mg/day from food). you’d be looking for a signal that’s smaller than the day-to-day noise from what you ate. the dissociation problem, if it’s a problem, is local. free cu2+ at the injection site reacting with whatever’s around before it gets buffered or chelated and carried off. serum draw a week later isn’t going to surface that, you’d see normal levels and conclude nothing’s happening when something might be happening at a tissue level you can’t sample. ceruloplasmin saturation, 24h urinary copper, or hair mineral analysis are closer to what you’d want and they all have their own issues. ymmv but i’d flag this as “asking the question is right, that’s just not the test that answers it.” clinician territory past this point fwiw.